JUMP valuation tool for the organisation Hep C disease management

Idylla – New generation of molecular diagnostic testing

Idylla – New generation of molecular diagnostic testing

Valuation tool developed based on data on Hep C care at the London Royal Free Hospital as well as national demographic data on Hep C patients to account for the location of patients with different genotypes, stages of disease, treatment status, etc. A clinician or administrator of a Hepatitis C clinic will be able to use the tool both based on data on patient numbers, patient characteristics, diagnostic and drug therapies prescribed, pathology lab set-up and turnaround times for processing viral load samples, as well as costs associated with clinic operation. If the user cannot supply specific data points, these will be automatically estimated by the tool.

 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *